Feasibility of a Wearable Remote Monitoring Device for Patients Treated for Opioid Use Disorder in a Telehealth Program
Rattachement africain : gb, us. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Opioid use disorder (OUD) is increasingly prevalent in the United States. Telehealth-only OUD treatment with buprenorphine, first permitted during the COVID-19 pandemic, has expanded access but the modality complicates monitoring medication adherence and withdrawal symptoms. Remote patient monitoring (RPM) using smartwatch biometric sensors may improve telehealth OUD care, but feasibility is unknown. Patients (N=15) newly treated in a telehealth OUD program receiving buprenorphine were enrolled. Subjects were instructed to wear a smartwatch continuously, except during charging, for ten days. Adherence, defined as the proportion of hours in which at least one biometric data capture occurred, was measured. The mean adherence was 38.9%. Six patients (40.0%) demonstrated high adherence (>50%), and nine (60.0%) had low adherence. Although adherence was suboptimal, smartwatch-based RPM may be feasible in a telehealth-only OUD treatment program for some patients.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Feasibility of a Wearable Remote Monitoring Device for Patients Treated for Opioid Use Disorder in a Telehealth Program
- Date Crossref
- 01/01/2026
- Éditeur
- Hawaii International Conference on System Sciences
- Type
- proceedings-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Les institutions déclarées
Une affiliation ne permet pas de déduire la nationalité d’un auteur.